Cargando…
Red Blood Cell Membrane-Coated Silica Nanoparticles Codelivering DOX and ICG for Effective Lung Cancer Therapy
[Image: see text] The effective chemotherapy of cancer is usually hindered by the unsatisfied cell internalization of the drug delivery systems (DDS) as well as drug resistance of cancer cells. In order to solve these dilemmas in one design, red blood cell membrane (RBM)-coated silica nanoparticles...
Autores principales: | Xiao, Jia, Weng, Jie, Wen, Fang, Ye, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774068/ https://www.ncbi.nlm.nih.gov/pubmed/33403246 http://dx.doi.org/10.1021/acsomega.0c01541 |
Ejemplares similares
-
Retraction of “Red Blood Cell Membrane-Coated
Silica Nanoparticles Codelivering DOX and ICG for Effective Lung Cancer
Therapy”
por: Xiao, Jia, et al.
Publicado: (2021) -
Multistage delivery of CDs-DOX/ICG-loaded liposome for highly penetration and effective chemo-photothermal combination therapy
por: Xue, Xiao, et al.
Publicado: (2018) -
PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells
por: Su, Wen-Pin, et al.
Publicado: (2012) -
MiR‐101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma
por: Xu, Fei, et al.
Publicado: (2017) -
Cetuximab-modified silica nanoparticle loaded with ICG for tumor-targeted combinational therapy of breast cancer
por: Zhang, Xiaoxue, et al.
Publicado: (2019)